What is AskBio?
AskBio is at the forefront of molecular medicine, dedicated to pioneering gene therapeutics through groundbreaking research, synthetic biology, and scalable cGMP manufacturing. The company's robust pipeline targets neuromuscular, central nervous system, metabolic, and cardiovascular diseases, offering hope for patients with unmet medical needs. With a substantial portfolio of over 775 molecular and genetic medicine patents and an extensive library of capsids and promoters, AskBio possesses a strong foundation for innovation. Its global operations span research centers in the US and Europe, complemented by advanced manufacturing facilities in Spain, positioning it as a key player in the global gene therapy landscape.
How much funding has AskBio raised?
AskBio has raised a total of $4.2M across 2 funding rounds:
Grant
$1.6M
Grant
$2.6M
Grant (2004): $1.6M with participation from Muscular Dystrophy Association
Grant (2020): $2.6M led by Scottish Enterprise
Key Investors in AskBio
Scottish Enterprise
Scottish Enterprise is a national economic development agency of the Scottish Government, focused on fostering business growth and innovation within Scotland.
Muscular Dystrophy Association
The Muscular Dystrophy Association is a non-profit organization dedicated to combating neuromuscular diseases through research, patient care, and advocacy.
What's next for AskBio?
The recent major strategic investment signifies a critical growth phase for AskBio, likely enabling the company to advance its clinical-stage candidates, expand its manufacturing capabilities, and further its research into novel gene therapy approaches. This backing from strategic partners will be instrumental in navigating the complex regulatory pathways and scaling operations to meet the growing demand for advanced therapeutic solutions. AskBio's focus on a broad spectrum of genetic diseases, coupled with its extensive intellectual property, positions it for continued leadership and impact in the molecular medicine sector.
See full AskBio company page
